A year since launching the international partnership, the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, CARB-X ,announced its second round of antibiotic research and development funding, awarding seven projects in six countries - two in the United States, and one each in France, India, Switzerland, Ireland and the United Kingdom.